Piero Bosio Social Web Site Personale

What is behind China’s rapid rise as a pharmaceutical powerhouse? > The next time you take a new prescription drug, there is a growing chance it was first developed in a laboratory in China.> The country has become one of the biggest sources of new drug candidates entering human trials globally.> According to Goldman Sachs Research, 46 per cent of new drug molecules entering human trials worldwide in the first half of 2025 came from Chinese biopharma companies.> Much of this activity is happening in Zhangjiang, a district in Shanghai where the streets are named after famous scientists such as Thomas Edison and Cai Lun.> Once known mainly as a technology hub, the area has earned a new nickname in recent years – “Pharma Valley” – because of the large number of biotech firms based there.> These companies are becoming an important source of innovative drugs and an increasingly significant part of the global pharmaceutical supply chain.https://www.channelnewsasia.com/east-asia/china-drugs-pharmaceutical-powerhouse-biotech-cancer-artificial-intelligence-5951486 ##Biopharma #China @schizoidman https://lemmy.zip/post/59750982